Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma.

Purpose Of Review: This review addresses the current treatment paradigm and new advancements in the management of microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) esophagogastric cancer (EGC).

Recent Findings: While chemotherapy and surgery remain the cornerstone of EGC treatment, MSI-H/dMMR tumors harbor high tumor mutational burden and represent a subset of patients who benefit from immune checkpoint inhibitors (ICI). ICI has been incorporated in the front line setting with and without chemotherapy for advanced disease.

Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle.

Background: This study aimed to evaluate the effects of 4-hexylresorcinol (4HR), a synthetic compound with antioxidant and stress-modulating properties, on diabetic sarcopenia in the masseter muscle.

Methods: A controlled, parallel-arm study was conducted using 38 Sprague-Dawley rats divided into diabetic and non-diabetic groups. Diabetes was induced with streptozotocin (STZ), and the groups were further subdivided to receive weekly subcutaneous injections of either 4HR or saline.

Stable H-O and radiogenic Sr isotopic ratios in bottled water in South Korea.

Stable H-O and radiogenic Sr isotopic compositions of bottled water in South Korea were investigated to trace water origins and to elucidate hydrogeochemical water-rock interactions within aquifers. Eighty-one bottled water samples were collected across the country. The δD and δO values, and Sr/Sr ratios and Sr contents of groundwater-sourced bottled water samples were in the ranges of -68 to -40 ‰, -10 to -7 ‰, 0.

Acute kidney injury after non-cardiac major surgery: has it reduced?

Background: It remains unclear whether the incidence of post-operative acute kidney injury (PO-AKI) has been reduced despite the recent emphasis on its early recognition and prevention in clinical practice. We aimed to investigate the trend in the incidence of PO-AKI and to identify the associated factors affecting its changes.

Methods: We gathered clinical data from patients who underwent non-cardiac major surgeries at three referral hospitals from 2005 to 2020.

Lung cancer organoid-based drug evaluation models and new drug development application trends.

Lung cancer is a malignant tumor with high incidence and mortality rates in both men and women worldwide. Although anticancer drugs are prescribed to treat lung cancer patients, individual responses to these drugs vary, making it crucial to identify the most suitable treatment for each patient. Therefore, it is necessary to develop an anticancer drug efficacy prediction model that can analyze drug efficacy before patient treatment and establish personalized treatment strategies.